TransMedics Group, Inc.TMDXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank11
3Y CAGR-29.5%
5Y CAGR-18.7%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-29.5%/yr
vs -12.3%/yr prior
5Y CAGR
-18.7%/yr
Recent deceleration
Acceleration
-17.2pp
Decelerating
Percentile
P11
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20256.83+45.5%
20244.69-55.8%
202310.62-45.6%
202219.52+11.6%
202117.49-8.8%
202019.17+67.6%
201911.44-65.4%
201833.06-21.5%
201742.13-19.2%
201652.14-